| LOVE Stock | | | CAD 0.70 0.02 2.78% |
Cannara Biotech financial indicator trend analysis is way more than just evaluating Cannara Biotech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cannara Biotech is a good investment. Please check the relationship between Cannara Biotech Selling General Administrative and its Research Development accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Cannara Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in income.
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Cannara Biotech Selling General Administrative account and
Research Development. At this time, the significance of the direction appears to have pay attention.
The correlation between Cannara Biotech's Selling General Administrative and Research Development is -0.81. Overlapping area represents the amount of variation of Selling General Administrative that can explain the historical movement of Research Development in the same time period over historical financial statements of Cannara Biotech, assuming nothing else is changed. The correlation between historical values of Cannara Biotech's Selling General Administrative and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling General Administrative of Cannara Biotech are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Selling General Administrative i.e., Cannara Biotech's Selling General Administrative and Research Development go up and down completely randomly.
Correlation Coefficient | -0.81 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Most indicators from Cannara Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cannara Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Cannara Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in income.
At this time, Cannara Biotech's
Enterprise Value Over EBITDA is fairly stable compared to the past year.
Enterprise Value Multiple is likely to climb to 7.13 in 2024, whereas Selling General Administrative is likely to drop slightly above 9.7
M in 2024.
When running Cannara Biotech's price analysis, check to
measure Cannara Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannara Biotech is operating at the current time. Most of Cannara Biotech's value examination focuses on studying past and present price action to
predict the probability of Cannara Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannara Biotech's price. Additionally, you may evaluate how the addition of Cannara Biotech to your portfolios can decrease your overall portfolio volatility.